June 2017 DAIT Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Autoimmunity Centers of Excellence, Basic Component/Clinical Component

For the published requests for applications, see the March 8, 2018 Guide announcements, Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed) and Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required).

NIAID Division of Allergy, Immunology, and Transplantation: Immune-Mediated Diseases Clinical Products Center (CPC)

For the published request for proposals, see the September 1, 2017 solicitation Immune-Mediated Diseases Clinical Products Center.

Investigations on Primary Immunodeficiency Diseases

For the published program announcement with special receipt, referral, and/or review considerations, see the March 15, 2017 Guide announcement, Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed).

SBIR Radiation and Nuclear Countermeasures Program

For the published program announcement, see the December 19, 2017 Guide announcement, Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed).

Immunity in the Elderly

For the published request for applications, see the October 25, 2017 Guide announcement, Immunity in the Elderly (R01, Clinical Trial Optional).

Immune Epitope Database and Analysis Program

For the published request for proposals, see the November 17, 2017 solicitation, Immune Epitope and Analysis Resource Program.

Content last reviewed on March 15, 2018